Aehr Test Systems (NASDAQ:AEHR) Shares Gap Down Following Insider Selling

Aehr Test Systems (NASDAQ:AEHR) shares gapped down before the market opened on Thursday after an insider sold shares in the company. The stock had previously closed at $129.23, but opened at $123.01. Aehr Test Systems shares last traded at $120.5230, with a volume of 859,938 shares.

Specifically, Director Laura Oliphant sold 1,717 shares of the business’s stock in a transaction dated Wednesday, August 12th. The stock was sold at an average price of $133.00, for a total value of $228,361.00. Following the transaction, the director directly owned 16,100 shares in the company, valued at $2,141,300. The trade was a 9.64% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Adil Engineer sold 15,000 shares of the company’s stock in a transaction dated Wednesday, August 12th. The stock was sold at an average price of $131.02, for a total value of $1,965,300.00. Following the completion of the transaction, the chief operating officer directly owned 46,977 shares of the company’s stock, valued at approximately $6,154,926.54. This trade represents a 24.20% decrease in their position. The disclosure for this sale is available in the SEC filing. In related news, Director Rhea J. Posedel sold 8,413 shares of the stock in a transaction dated Wednesday, August 12th. The stock was sold at an average price of $130.00, for a total transaction of $1,093,690.00. Following the completion of the sale, the director owned 387,962 shares in the company, valued at approximately $50,435,060. This trade represents a 2.12% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Analyst Ratings Changes

A number of research analysts recently commented on AEHR shares. Zacks Research raised Aehr Test Systems from a “hold” rating to a “strong-buy” rating in a report on Friday, July 17th. Lake Street Capital reaffirmed a “buy” rating and set a $110.00 price objective on shares of Aehr Test Systems in a report on Wednesday, July 15th. Freedom Capital raised shares of Aehr Test Systems from a “hold” rating to a “strong-buy” rating in a report on Thursday, July 16th. Jefferies Financial Group began coverage on shares of Aehr Test Systems in a research report on Thursday. They set a “buy” rating and a $175.00 price objective on the stock. Finally, Weiss Ratings downgraded Aehr Test Systems from a “sell (d)” rating to a “sell (e+)” rating in a research report on Wednesday, July 29th. Two equities research analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of $136.67.

More Aehr Test Systems News

Here are the key news stories impacting Aehr Test Systems this week:

• Positive Sentiment: Jefferies initiated coverage with a bullish view, helping drive renewed investor interest. The analyst reportedly described the price target as conservative and identified additional potential catalysts that were not included in the model. Jefferies Initiates Coverage on Aehr Test Systems
• Positive Sentiment: Aehr received a $22 million follow-on order from its lead customer for wafer-level burn-in systems used with advanced AI training and inference processors. The repeat business supports demand for the company’s FOX systems and strengthens its position in AI and high-performance computing. Aehr Receives $22 Million Follow-on Order
• Positive Sentiment: Recent company updates pointed to record quarterly bookings of $60.7 million, a backlog of approximately $100.6 million and fiscal 2027 revenue guidance of $130 million to $150 million. These figures provide revenue visibility and support the investment case tied to rising AI-chip testing demand. Aehr AI Order and WLBI Opportunity
• Neutral Sentiment: CEO Gayn Erickson and CFO Chris Siu will meet investors at the Needham Virtual Semiconductor and SemiCap 1×1 Conference on August 19. The event could provide further commentary on backlog conversion and fiscal 2027 execution, but no new financial information was announced. Aehr to Participate in Needham Conference
• Negative Sentiment: Several insiders sold shares after AEHR’s sharp rally. The transactions included the CEO’s sale of 40,000 shares for about $5.2 million, the COO’s sale of 15,000 shares for roughly $2.0 million, and additional director and executive sales. Although insiders retained sizable positions—and the CEO sale came from a trust—such activity may signal profit-taking and add selling pressure. Aehr CEO Share Sale
• Negative Sentiment: One analyst began coverage on a bearish note, highlighting the risk that expectations have become difficult to meet after the stock’s extraordinary advance. AEHR’s elevated valuation and dependence on continued AI order growth leave it vulnerable if bookings, backlog conversion or execution disappoints. Bearish Analyst Initiation

Aehr Test Systems Stock Up 8.7%

The company has a 50 day simple moving average of $92.83 and a two-hundred day simple moving average of $71.45. The company has a market capitalization of $4.37 billion, a P/E ratio of -558.56 and a beta of 3.10.

Institutional Investors Weigh In On Aehr Test Systems

Several institutional investors have recently modified their holdings of AEHR. Vanguard Group Inc. raised its holdings in Aehr Test Systems by 2.2% during the 4th quarter. Vanguard Group Inc. now owns 2,337,433 shares of the semiconductor company’s stock valued at $47,193,000 after buying an additional 49,243 shares during the period. Halter Ferguson Financial Inc. lifted its position in Aehr Test Systems by 41.7% in the fourth quarter. Halter Ferguson Financial Inc. now owns 642,129 shares of the semiconductor company’s stock worth $12,965,000 after buying an additional 189,117 shares during the last quarter. State of Alaska Department of Revenue purchased a new position in Aehr Test Systems during the fourth quarter worth $377,000. UBS Group AG boosted its stake in Aehr Test Systems by 55.7% during the fourth quarter. UBS Group AG now owns 243,129 shares of the semiconductor company’s stock worth $4,909,000 after buying an additional 87,014 shares during the period. Finally, Universal Beteiligungs und Servicegesellschaft mbH bought a new position in Aehr Test Systems during the fourth quarter valued at $407,000. 69.69% of the stock is owned by institutional investors.

About Aehr Test Systems

Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.

The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.